• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Nationally Syndicated Radio Program Interviews Coalition for Pulmonary Fibrosis, University of Chicago Doctor, About Deadly Lung Disease

Posted on: Monday, 27 November 2006, 12:01 CST

SAN JOSE, Calif., Nov. 27 /PRNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) is featured in a "Radio Health Journal" interview to air nationwide next week on more than 400 radio stations who air the syndicated show.

CPF Vice President of Patient Outreach & Advocacy Teresa Geiger, and Imre Noth, M.D., assistant professor of medicine at the University of Chicago, were interviewed by the award winning radio show's Reed Pence. Their 10 minute interview is the second of three interviews included in the 28-minute program.

"The interview was wonderful and I hope this exposure helps to raise awareness of Idiopathic Pulmomary Fibrosis (IPF)", said Dr. Noth... "Along with the CPF, we at the University of Chicago hope to have a meaningful impact in this disease."

In the interview, Geiger and Dr. Noth share pertinent information on the devastating and deadly lung disease that affects 128,000 Americans. Incidence and prevalence estimates have increased more than 150 percent in the last five years.

To listen to the Radio Health Journal via the Internet, please use this link: http://www.mediatracks.com/rhj0648

To learn more about the CPF and its efforts to raise awareness of IPF, please visit http://www.coalitionforpf.org/ or call (888) 222-8541.

About Idiopathic Pulmonary Fibrosis (IPF)

IPF is a lung disorder characterized by a progressive scarring - known as fibrosis - and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from IPF, which is the most prevalent of a classification of lung disorders known as interstitial lung diseases (ILD's). There is currently no known cause or cure for IPF, nor is there an FDA-approved treatment. An estimated 48,000 new cases are diagnosed each year. IPF is difficult to diagnose, and an estimated two- thirds of patients die within five years of diagnosis.

About the Coalition for Pulmonary Fibrosis

The Coalition for Pulmonary Fibrosis (CPF) is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for idiopathic pulmonary fibrosis (IPF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure pulmonary fibrosis; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of IPF issues; and works to improve awareness of IPF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 10,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with pulmonary fibrosis. For more information please visit http://www.coalitionforpf.org/ or call (888) 222-8541.

Coalition for Pulmonary Fibrosis

CONTACT: Teresa Geiger of Coalition for Pulmonary Fibrosis,+1-888-222-8541, ext. 702, or mobile, +1-303-521-4080, ortgeiger@coalitionforpf.org

Web site: http://www.coalitionforpf.org/

Source: PRNewswire

More News in this Category